will follow the regulatory roadmap below, courtesy of
Steps to Accomplish
-
is a Class III device with no substantial equivalent
- Submit a new application for de novo down-classification
- FDA classifies device as low risk
- Enter de novo premarket evaluation process
- Publish Clinical Trials
- Publish Non-clinical Safety Tests
- Acquire regulatory approval and certification